To test this hypothesis, we evaluated the feasibility of combining ZD6474, a dual tyrosine kinase inhibitor of VEGFR and EGFR [29-32], with UV-B radiation in breast cancer cell lines MCF-7, MDA-MB-231, MDA-MB-468 and T-47D. Here, KDR is linked to breast cancer.